Stock MANKIND MANKIND PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Mankind Pharma Limited

Equities

MANKIND

INE634S01028

Delayed NSE India S.E.
Other stock markets
 08:15:33 18/05/2024 BST 		5-day change 1st Jan Change
2,112 INR +1.00% Intraday chart for Mankind Pharma Limited -5.59% +6.51%
05-16 Transcript : Mankind Pharma Limited, Q4 2024 Earnings Call, May 16, 2024
05-16 Mankind Pharma's Consolidated Profit Jumps in Fiscal Q4 MT

Evolution of the average Target Price on Mankind Pharma Limited

Price target over the last 5 years

History of analyst recommendation changes

01d517447cb68bcccf997308524.2lWlz22TZt2_GlFTMlvcvOXPJPcWp83H-KvyWGaoysQ.uGPnlVujCbnlRQcqWjTo0rqmaoRm7YasjtOjOQzFpvS9AOKeIKMUm8ZOaQ~863548451201ff46f5fb569116424d18

Analyst Recommendations on Mankind Pharma Limited

CARE Gives AA+ Rating to Mankind Pharma's Long-term Bank Financing; Outlook Stable MT
Jefferies Adjusts Mankind Pharma's Price Target to INR1,850 From INR1,870, Keeps at Hold MT
Jefferies Adjusts Mankind Pharma's Price Target to INR1,870 From INR1,830, Keeps at Hold MT
Indian shares set to open marginally higher amid global slide RE
INDIA STOCKS-Indian shares end higher on hopes of Fed rate hike pause RE
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
2,112 INR
Average target price
2,209 INR
Spread / Average Target
+4.63%
High Price Target
2,554 INR
Spread / Highest target
+20.95%
Low Price Target
1,750 INR
Spread / Lowest Target
-17.13%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Mankind Pharma Limited

Jefferies & Co.

Ratings for Mankind Pharma Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MANKIND Stock
  4. Consensus Mankind Pharma Limited